Skip to main content
SpringerLink
Log in

Transitioning Aerosol from Hospital to Home; Role of Training and Follow-Up

  • Chapter
  • First Online:
Essentials of Aerosol Therapy in Critically ill Patients

  • 625 Accesses

Abstract

Management of chronic respiratory disorders is a complex process that involves patient incorporation in the management plan for successful control of the disease. The participation of the patient in the management process should be through training of the patient by qualified healthcare professionals on the optimum inhalation techniques for the prescribed inhalers in successive counseling sessions. A lot of tools, applications, and devices are available for aiding asthma and chronic obstructive pulmonary disease (COPD) patients to use their inhalers correctly and to monitor patient adherence to aerosol therapy. Assessment tools are available to monitor disease control, these tools are questionnaire-based which collect data from the patient regarding symptoms, use of inhalers, and lung function. This chapter aims to discuss the different tools available for the assessment of respiratory diseases in which patients are using aerosol therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Thoonen B, et al. Self-management of asthma in general practice, asthma control and quality of life: a randomised controlled trial. Thorax. 2003;58(1):30–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Guevara JP, et al. Effects of educational interventions for self management of asthma in children and adolescents: systematic review and meta-analysis. BMJ. 2003;326(7402):1308–9.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Aydemir Y. Assessment of the factors affecting the failure to use inhaler devices before and after training. Respir Med. 2015;109(4):451–8.

    Article  PubMed  Google Scholar 

  4. Newman SP. Aerosol deposition considerations in inhalation therapy. Chest. 1985;88(2):152S–60S.

    Article  CAS  PubMed  Google Scholar 

  5. Bartolo K, et al. Predictors of correct technique in patients using pressurized metered dose inhalers. BMC Pulm Med. 2017;17(1):47.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Spin P, et al. A cost analysis of salbutamol administration by metered-dose inhalers with spacers versus nebulization for patients with wheeze in the pediatric emergency department: evidence from observational data in Nova Scotia. Can J Emerg Med. 2017;19(1):1–8.

    Article  Google Scholar 

  7. Al-Subu AM, et al. Aerosol therapy through high flow nasal cannula in pediatric patients. Expert Rev Respir Med. 2017;11(12):945–53.

    CAS  PubMed  Google Scholar 

  8. Fonceca AM, et al. Drug administration by inhalation in children. In: Kendig’s disorders of the respiratory tract in children, 9th ed. Elsevier; 2019. p. 257–271.e3.

    Google Scholar 

  9. Lexmond AJ, et al. Prerequisites for a dry powder inhaler for children with cystic fibrosis. PLoS One. 2017;12(8):e0183130.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  10. Ammari WG, Chrystyn H. Optimizing the inhalation flow and technique through metered dose inhalers of asthmatic adults and children attending a community pharmacy. J Asthma. 2013;50(5):505–13.

    Article  PubMed  Google Scholar 

  11. Nicola M, et al. The impact of adding a training device to familiar counselling on inhalation technique and pulmonary function of asthmatics. Adv Ther. 2018;35(7):1049–58.

    Article  PubMed  Google Scholar 

  12. Rogliani P, et al. Optimizing drug delivery in COPD: the role of inhaler devices. Respir Med. 2017;124:6–14.

    Article  PubMed  Google Scholar 

  13. Melani AS, et al. Inhaler mishandling remains common in real life and is associated with reduced disease control. Respir Med. 2011;105(6):930–8.

    Article  PubMed  Google Scholar 

  14. Vestbo J, et al. Adherence to inhaled therapy, mortality and hospital admission in COPD. Thorax. 2009;64(11):939–43.

    Article  CAS  PubMed  Google Scholar 

  15. DiMatteo MR. Variations in patients’ adherence to medical recommendations: a quantitative review of 50 years of research. Med Care. 2004;42(3):200–9.

    Article  PubMed  Google Scholar 

  16. Bender BG, et al. Adherence and persistence with fluticasone propionate/salmeterol combination therapy. J Allergy Clin Immunol. 2006;118(4):899–904.

    Article  CAS  PubMed  Google Scholar 

  17. Haupt D, et al. Medication persistence among patients with asthma/COPD drugs. Pharm World Sci. 2008;30(5):509–14.

    Article  PubMed  Google Scholar 

  18. Jónasson G, Carlsen K-H, Mowinckel PJ. Asthma drug adherence in a long term clinical trial. Arch Dis Child. 2000;83(4):330–3.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Jung E, et al. Medication adherence and persistence in the last year of life in COPD patients. Respir Med. 2009;103(4):525–34.

    Article  PubMed  Google Scholar 

  20. Hardwell A, et al. Technique training does not improve the ability of most patients to use pressurised metered-dose inhalers (pMDIs). Prim Care Respir J. 2011;20(1):92–6.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Lavorini F, et al. Effect of incorrect use of dry powder inhalers on management of patients with asthma and COPD. Respir Med. 2008;102(4):593–604.

    Article  PubMed  Google Scholar 

  22. Lenney J, Innes J, Crompton GJ. Inappropriate inhaler use: assessment of use and patient preference of seven inhalation devices. Respir Med. 2000;94(5):496–500.

    Article  CAS  PubMed  Google Scholar 

  23. Kim S-H, et al. Inappropriate techniques used by internal medicine residents with three kinds of inhalers (a metered dose inhaler, Diskus, and Turbuhaler): changes after a single teaching session. J Asthma. 2009;46(9):944–50.

    Article  PubMed  Google Scholar 

  24. Self TH, et al. Inadequate skill of healthcare professionals in using asthma inhalation devices. J Asthma. 2007;44(8):593–8.

    Article  PubMed  Google Scholar 

  25. Rau JL. Determinants of patient adherence to an aerosol regimen. Respir Care. 2005;50(10):1346–59.

    PubMed  Google Scholar 

  26. Elgendy MO, Abdelrahim ME, Eldin RS. Potential benefit of repeated MDI inhalation technique counselling for patients with asthma. Eur J Hosp Pharm. 2015;22(6):318–22.

    Article  Google Scholar 

  27. Saeed H, et al. Impact of advanced patient counseling using a training device and smartphone application on asthma control. Respir Care. 2020;65(3):326–32.

    Article  PubMed  Google Scholar 

  28. Fink JB, Rubin BK. Problems with inhaler use: a call for improved clinician and patient education. Respir Care. 2005;50(10):1360–75.

    PubMed  Google Scholar 

  29. Rubin BK, Durotoye LJC. How do patients determine that their metered-dose inhaler is empty? Chest. 2004;126(4):1134–7.

    Article  PubMed  Google Scholar 

  30. Ibrahim M, Verma R, Garcia-Contreras L. Inhalation drug delivery devices: technology update. Med Devices (Auckland, NZ). 2015;8:131.

    Google Scholar 

  31. Dal Negro RW. Dry powder inhalers and the right things to remember: a concept review. Multidiscip Respir Med. 2015;10(1):13.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Abdelrahim M, Assi K, Chrystyn H. Dose emission and aerodynamic characterization of the terbutaline sulphate dose emitted from a Turbuhaler at low inhalation flow. Pharm Dev Technol. 2013;18(4):944–9.

    Article  CAS  PubMed  Google Scholar 

  33. Ali AMA, Abdelrahim MEA. Modeling and optimization of terbutaline emitted from a dry powder inhaler and influence on systemic bioavailability using data mining technology. J Pharm Innov. 2014;9(1):38–47.

    Article  Google Scholar 

  34. Abdelrahim ME. Emitted dose and lung deposition of inhaled terbutaline from Turbuhaler at different conditions. Respir Med. 2010;104(5):682–9.

    Article  PubMed  Google Scholar 

  35. Chapman KR, et al. Delivery characteristics and patients’ handling of two single-dose dry-powder inhalers used in COPD. Int J Chron Obstruct Pulmon Dis. 2011;6(1):353–63.

    PubMed  PubMed Central  Google Scholar 

  36. Newman S, Busse W. Evolution of dry powder inhaler design, formulation, and performance. Respir Med. 2002;96(5):293–304.

    Article  CAS  PubMed  Google Scholar 

  37. Tarsin W, Assi KH, Chrystyn H. In-vitro intra- and inter-inhaler flow rate-dependent dosage emission from a combination of budesonide and eformoterol in a dry powder inhaler. J Aerosol Med. 2004;17(1):25–32.

    Article  CAS  PubMed  Google Scholar 

  38. von Schantz S, et al. Evaluation of dry powder inhalers with a focus on ease of use and user preference in inhaler-naïve individuals. Int J Pharm. 2016;509(1):50–8.

    Article  CAS  Google Scholar 

  39. Yun Kirby S, et al. A preference study of two placebo dry powder inhalers in adults with COPD: Ellipta® dry powder inhaler (DPI) versus DISKUS® DPI. COPD: J Chron Obstruct Pulmon Dis. 2016;13(2):167–75.

    Article  Google Scholar 

  40. Hamilton M, et al. In vitro dosing performance of the ELLIPTA® dry powder inhaler using asthma and COPD patient inhalation profiles replicated with the electronic lung (eLung™). J Aerosol Med Pulm Drug Deliv. 2015;28(6):498–506.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Komase Y, et al. Ease-of-use preference for the ELLIPTA® dry powder inhaler over a commonly used single-dose capsule dry powder inhaler by inhalation device-naïve Japanese volunteers aged 40 years or older. Int J Chron Obstruct Pulmon Dis. 2014;9:1365.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Grant AC, et al. The ELLIPTA® dry powder inhaler: design, functionality, in vitro dosing performance and critical task compliance by patients and caregivers. J Aerosol Med Pulm Drug Deliv. 2015;28(6):474–85.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Eisen SA, et al. The effect of prescribed daily dose frequency on patient medication compliance. Arch Intern Med. 1990;150(9):1881–4.

    Article  CAS  PubMed  Google Scholar 

  44. Claxton AJ, Cramer J, Pierce CJ. A systematic review of the associations between dose regimens and medication compliance. Clin Ther. 2001;23(8):1296–310.

    Article  CAS  PubMed  Google Scholar 

  45. Stoloff SW, et al. Improved refill persistence with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies. J Allergy Clin Immunol. 2004;113(2):245–51.

    Article  PubMed  Google Scholar 

  46. Sovani MP, et al. Poor adherence with inhaled corticosteroids for asthma: can using a single inhaler containing budesonide and formoterol help? Br J Gen Pract. 2008;58(546):37–43.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Bender B, et al. Adherence intervention research: what have we learned and what do we do next? J Allergy Clin Immunol. 2003;112(3):489–94.

    Article  PubMed  Google Scholar 

  48. Graves MM, et al. Volitional nonadherence in pediatric asthma: parental report of motivating factors. Curr Allergy Asthma Rep. 2007;7(6):427–32.

    Article  PubMed  Google Scholar 

  49. Ari A, Restrepo RD. Aerosol delivery device selection for spontaneously breathing patients: 2012. Respir Care. 2012;57(4):613–26.

    Article  PubMed  Google Scholar 

  50. DiMatteo MR, Haskard KB, Williams SL. Health beliefs, disease severity, and patient adherence: a meta-analysis. Med Care, 45. 2007:521–8.

    Google Scholar 

  51. Serra-Batlles J, et al. Patient perception and acceptability of multidose dry powder inhalers: a randomized crossover comparison of Diskus/Accuhaler with Turbuhaler. J Aerosol Med. 2002;15(1):59–64.

    Article  PubMed  Google Scholar 

  52. Fan VS, et al. Costs of pulmonary rehabilitation and predictors of adherence in the National Emphysema Treatment Trial. COPD. 2008;5(2):105–16.

    Article  PubMed  Google Scholar 

  53. Le TT, et al. Do asthma medication beliefs mediate the relationship between minority status and adherence to therapy? J Asthma. 2008;45(1):33–7.

    Article  PubMed  Google Scholar 

  54. Schulte M, et al. Handling of and preferences for available dry powder inhaler systems by patients with asthma and COPD. J Aerosol Med Pulm Drug Deliv. 2008;21(4):321–8.

    Article  CAS  PubMed  Google Scholar 

  55. Rubin BK. What does it mean when a patient says,“my asthma medication is not working?”. Chest. 2004;126(3):972–81.

    Article  PubMed  Google Scholar 

  56. Menckeberg TT, et al. Patients’ understanding of the reasons for starting and discontinuing inhaled corticosteroids. Br J Clin Pharmacol. 2008;66(2):255–60.

    Article  PubMed  PubMed Central  Google Scholar 

  57. Eakin MN, Rand CS. Improving patient adherence with asthma self-management practices: what works? Ann Allery Asthma Immunol. 2012;109(2):90–2.

    Article  Google Scholar 

  58. Saeed H, et al. Effect of human error, inhalation flow, and inhalation volume on dose delivery from Ellipta® dry-powder inhaler. J Pharm Innov. 2019;14(3):239–44.

    Article  Google Scholar 

  59. Elgendy MO, et al. Asthmatic children and MDI verbal inhalation technique counseling. Pulm Pharmacol Ther. 2020;61:101900.

    Article  CAS  PubMed  Google Scholar 

  60. Elgendy MO, Abdelrahim ME, Eldin RS. Potential benefit of repeated dry powder inhaler’s inhalation technique counseling on asthmatic patients. Pulm Ther. 2015;1(1):91–101.

    Article  Google Scholar 

  61. Lavorini F, et al. The ADMIT series-issues in inhalation therapy. 6. Training tools for inhalation devices. Prim Care Respir J. 2010;19(4):335–41.

    Article  PubMed  PubMed Central  Google Scholar 

  62. Kamin WE, et al. The inhalation manager: a new computer-based device to assess inhalation technique and drug delivery to the patient. J Aerosol Med. 2003;16(1):21–9.

    Article  CAS  PubMed  Google Scholar 

  63. Ari AJ. Patient education and adherence to aerosol therapy. Respir Care. 2015;60(6):941–57.

    PubMed  Google Scholar 

  64. Molimard M, Colthorpe P. Inhaler devices for chronic obstructive pulmonary disease: insights from patients and healthcare practitioners. J Aerosol Med Pulm Drug Deliv. 2015;28(3):219–28.

    Article  PubMed  PubMed Central  Google Scholar 

  65. Ari A, Fink JB. Guidelines for aerosol devices in infants, children and adults: which to choose, why and how to achieve effective aerosol therapy. Expert Rev Respir Med. 2011;5(4):561–72.

    Article  PubMed  Google Scholar 

  66. Basheti IA, et al. Evaluation of a novel educational strategy, including inhaler-based reminder labels, to improve asthma inhaler technique. Patient Educ Couns. 2008;72(1):26–33.

    Article  PubMed  Google Scholar 

  67. Safeer RS, Keenan JJ. Health literacy: the gap between physicians and patients. Am Fam Physician. 2005;72(3):463–8.

    PubMed  Google Scholar 

  68. Goodyer L, et al. Inhaler technique in Turkish people with poor English: a case of information discrimination? Pharm World Sci. 2006;28(2):107–14.

    Article  PubMed  Google Scholar 

  69. Skaer T, et al. Metered-dose inhaler technique and quality of life with airways disease: assessing the value of the Vitalograph in educational intervention. J Int Med Res. 1996;24(4):369–75.

    Article  CAS  PubMed  Google Scholar 

  70. Manuyakorn W, et al. Sensitivity of Turbutester and Accuhaler tester in asthmatic children and adolescents. Pediatr Int. 2010;52(1):118–25.

    Article  PubMed  Google Scholar 

  71. Al-Showair RA, Pearson SB, Chrystyn HJC. The potential of a 2Tone Trainer to help patients use their metered-dose inhalers. Chest. 2007;131(6):1776–82.

    Article  PubMed  Google Scholar 

  72. Azouza W, Chrystyn HJ. Clarifying the dilemmas about inhalation techniques for dry powder inhalers: integrating science with clinical practice. Prim Care Respir J. 2012;21(2):208–13.

    Article  PubMed Central  Google Scholar 

  73. Amirav I, Newhouse MT, Mansour YJ. Measurement of peak inspiratory flow with in-check dial device to simulate low-resistance (Diskus) and high-resistance (Turbohaler) dry powder inhalers in children with asthma. Pediatr Pulmonol. 2005;39(5):447–51.

    Article  PubMed  Google Scholar 

  74. Wael W, et al. The effect of clip-tone® and its smartphone application on optimization of metered-dose inhaler inhalation technique. Eur Respir Soc. 2020;56:4157.

    Google Scholar 

  75. Bender B, et al. Measurement of children’s asthma medication adherence by self report, mother report, canister weight, and doser CT. Ann Allergy Asthma Immunol. 2000;85(5):416–21.

    Article  CAS  PubMed  Google Scholar 

  76. Chan AHY, et al. Using electronic monitoring devices to measure inhaler adherence: a practical guide for clinicians. J Allergy Clin Immunol Pract. 2015;3(3):335–349.e5.

    Article  PubMed  Google Scholar 

  77. McQuaid EL, et al. Medication adherence in pediatric asthma: reasoning, responsibility, and behavior. J Pediatr Psychol. 2003;28(5):323–33.

    Article  PubMed  Google Scholar 

  78. Sherman J, et al. Telephoning the patient’s pharmacy to assess adherence with asthma medications by measuring refill rate for prescriptions. J Pediatr. 2000;136(4):532–6.

    Article  CAS  PubMed  Google Scholar 

  79. Schatz M, et al. Validity of the Asthma Control Test™ completed at home. Am J Manag Care. 2007;13(12):661.

    PubMed  Google Scholar 

  80. Peters SP, et al. Real-world Evaluation of Asthma Control and Treatment (REACT): findings from a national Web-based survey. J Allergy Clin Immunol. 2007;119(6):1454–61.

    Article  PubMed  Google Scholar 

  81. Okupa AY, et al. Daily diaries vs retrospective questionnaires to assess asthma control and therapeutic responses in asthma clinical trials: is participant burden worth the effort? Chest. 2013;143(4):993–9.

    Article  PubMed  PubMed Central  Google Scholar 

  82. Jia CE, et al. The Asthma Control Test and Asthma Control Questionnaire for assessing asthma control: systematic review and meta-analysis. J Allergy Clin Immunol. 2013;131(3):695–703.

    Article  PubMed  Google Scholar 

  83. Pijnenburg MW, et al. Monitoring asthma in children. Eur Respir J. 2015;45(4):906–25.

    Article  PubMed  Google Scholar 

  84. Juniper EF, et al. Identifying ‘well-controlled’and ‘not well-controlled’ asthma using the Asthma Control Questionnaire. Respir Med. 2006;100(4):616–21.

    Article  PubMed  Google Scholar 

  85. Álvarez-Gutiérrez FJ, et al. Relationship of the Asthma Control Test (ACT) with lung function, levels of exhaled nitric oxide and control according to the Global Initiative for Asthma (GINA). Arch Bronconeumol. 2010;46(7):370–7.

    Article  PubMed  Google Scholar 

  86. Meltzer EO, et al. Use of the Asthma Control Questionnaire to predict future risk of asthma exacerbation. J Allergy Clin Immunol. 2011;127(1):167–72.

    Article  PubMed  Google Scholar 

  87. Ko FW, et al. Evaluation of the asthma control test: a reliable determinant of disease stability and a predictor of future exacerbations. Respirology. 2012;17(2):370–8.

    Article  PubMed  Google Scholar 

  88. Forno E, et al. Risk factors and predictive clinical scores for asthma exacerbations in childhood. Chest. 2010;138(5):1156–65.

    Article  PubMed  PubMed Central  Google Scholar 

  89. Voorend-van Bergen S, et al. Asthma control questionnaires in the management of asthma in children: a review. Pediatr Pulmonol. 2015;50(2):202–8.

    Article  CAS  PubMed  Google Scholar 

  90. Juniper EF, et al. Asthma Control Questionnaire in children: validation, measurement properties, interpretation. Eur Respir J. 2010;36(6):1410–6.

    Article  CAS  PubMed  Google Scholar 

  91. Juniper E, et al. Development and validation of a questionnaire to measure asthma control. Eur Respir J. 1999;14(4):902–7.

    Article  CAS  PubMed  Google Scholar 

  92. Olaguibel JM, et al. Measurement of asthma control according to Global Initiative for Asthma guidelines: a comparison with the Asthma Control Questionnaire. Respir Res. 2012;13(1):1–10.

    Article  Google Scholar 

  93. McCallister JW, et al. Sex differences in asthma symptom profiles and control in the American Lung Association Asthma Clinical Research Centers. Respir Med. 2013;107(10):1491–500.

    Article  PubMed  Google Scholar 

  94. Liu AH, et al. Development and cross-sectional validation of the Childhood Asthma Control Test. J Allergy Clin Immunol. 2007;119(4):817–25.

    Article  PubMed  Google Scholar 

  95. Schatz M, et al. Asthma Control Test: reliability, validity, and responsiveness in patients not previously followed by asthma specialists. J Allergy Clin Immunol. 2006;117(3):549–56.

    Article  PubMed  Google Scholar 

  96. Nathan RA, et al. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol. 2004;113(1):59–65.

    Article  PubMed  Google Scholar 

  97. Schatz M, et al. The minimally important difference of the Asthma Control Test. J Allergy Clin Immunol. 2009;124(4):719–723.e1.

    Article  PubMed  Google Scholar 

  98. Skinner EA, et al. The asthma therapy assessment questionnaire (ATAQ) for children and adolescents. Dis Manag. 2004;7(4):305–13.

    Article  PubMed  Google Scholar 

  99. Cloutier MM, et al. Asthma outcomes: composite scores of asthma control. J Allergy Clin Immunol. 2012;129(3):S24–33.

    Article  PubMed  PubMed Central  Google Scholar 

  100. Diette GB, et al. Using the pediatric asthma therapy assessment questionnaire to measure asthma control and healthcare utilization in children. Patient. 2009;2(4):233–41.

    Article  PubMed  Google Scholar 

  101. Murphy KR, et al. Test for respiratory and asthma control in kids (TRACK): a caregiver-completed questionnaire for preschool-aged children. J Allergy Clin Immunol. 2009;123(4):833–839.e9.

    Article  PubMed  Google Scholar 

  102. Zeiger RS, et al. Test for Respiratory and Asthma Control in Kids (TRACK): clinically meaningful changes in score. J Allergy Clin Immunol. 2011;128(5):983–8.

    Article  PubMed  Google Scholar 

  103. Jones P, et al. Development and first validation of the COPD Assessment Test. Eur Respir J. 2009;34(3):648–54.

    Article  CAS  PubMed  Google Scholar 

  104. Van der Molen T, et al. Development, validity and responsiveness of the Clinical COPD Questionnaire. Health Qual Life Outcomes. 2003;1(1):1–10.

    Article  Google Scholar 

  105. Kon SS, et al. The Clinical COPD Questionnaire: response to pulmonary rehabilitation and minimal clinically important difference. Thorax. 2014;69(9):793–8.

    Article  PubMed  Google Scholar 

  106. Rabe KF, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007;176(6):532–55.

    Article  PubMed  Google Scholar 

  107. Ringbaek T, Martinez G, Lange PJ. A comparison of the assessment of quality of life with CAT, CCQ, and SGRQ in COPD patients participating in pulmonary rehabilitation. COPD. 2012;9(1):12–5.

    Article  PubMed  Google Scholar 

  108. Tsiligianni IG, et al. Assessing health status in COPD. A head-to-head comparison between the COPD assessment test (CAT) and the clinical COPD questionnaire (CCQ). BMC Pulm Med. 2012;12(1):1–9.

    Article  Google Scholar 

  109. Cave AJ, et al. Assessment of COPD wellness tools for use in primary care: an IPCRG initiative. Int J Chron Obstruct Pulmon Dis. 2012;7:447.

    Article  PubMed  PubMed Central  Google Scholar 

  110. Toumas-Shehata M, et al. Exploring the role of quantitative feedback in inhaler technique education: a cluster-randomised, two-arm, parallel-group, repeated-measures study. NPJ Prim Care Respir Med. 2014;24(1):1–6.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Pharmacy, Beni-Suef University, Beni-Suef, Egypt

    Mohamed E. A. Abdelrahim, Haitham Saeed, Hadeer S. Harb & Yasmin M. Madney

Authors
  1. Mohamed E. A. Abdelrahim
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Haitham Saeed
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hadeer S. Harb
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yasmin M. Madney
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Abdelrahim, M.E.A., Saeed, H., Harb, H.S., Madney, Y.M. (2021). Transitioning Aerosol from Hospital to Home; Role of Training and Follow-Up. In: Essentials of Aerosol Therapy in Critically ill Patients. Springer, Cham. https://doi.org/10.1007/978-3-030-85026-5_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-85026-5_5

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-85025-8

  • Online ISBN: 978-3-030-85026-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation